IART Q4 2022 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena

IARTIntegra LifeSciences Holdings Corporation

$738M

Q4 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$398M-1.8% YoY

Gross Profit

$250M62.8% margin

Operating Income

$68M17.0% margin

Net Income

$53M13.3% margin

EPS (Diluted)

$0.63

QoQ Revenue Growth

+3.3%

Cash Flow

Operating Cash Flow

$85M

Free Cash Flow

$71M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$3.9B

Total Liabilities

$2.1B

Stockholders' Equity

$1.8B

Cash & Equivalents

$457M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$398M	$406M	-1.8%
Gross Profit	$250M	$249M	+0.3%
Operating Income	$68M	$58M	+16.5%
Net Income	$53M	$45M	+16.7%

Revenue Segments

Codman Specialty Surgical

$265M66%

Tissue Technologies

$133M34%

Geographic Segments

UNITED STATES

$294M74%

Asia Pacific

$43M11%

Europe

$42M11%

Rest Of World

$19M5%